{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:54:31Z","timestamp":1791262471212,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2022MC157"],"award-info":[{"award-number":["ZR2022MC157"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110444","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:01:04Z","timestamp":1788390064000},"page":"110444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antitumor activity of a Schiff base copper(II) complex against triple-negative breast cancer via ferroptosis and autophagy pathways"],"prefix":"10.1016","volume":"182","author":[{"given":"Huannan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maocai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110444_bb0005","first-page":"95","article-title":"Triple negative breast cancer: pitfalls and progress, npj","volume":"8","author":"Zagami","year":"2022","journal-title":"Breast Cancer"},{"key":"10.1016\/j.bioorg.2026.110444_bb0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of triple-negative breast cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"key":"10.1016\/j.bioorg.2026.110444_bb0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.110444_bb0020","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2026.110444_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104351","article-title":"Recent strategies to overcome breast cancer resistance","volume":"197","author":"Khan","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bioorg.2026.110444_bb0030","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3390\/jpm11080808","article-title":"Breast cancer treatments: updates and new challenges","volume":"11","author":"Burguin","year":"2021","journal-title":"Journal of Personalized Medicine"},{"key":"10.1016\/j.bioorg.2026.110444_bb0035","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110444_bb0040","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.110444_bb0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.110444_bb0050","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110444_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02567-5","article-title":"Ferroptosis in cancer toward molecular insights and clinical translation in pancreatic cancer","volume":"25","author":"Chen","year":"2026","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2026.110444_bb0060","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41467-026-68547-5","article-title":"Ether lipids influence cancer cell fate by modulating iron uptake","volume":"17","author":"Mansell","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110444_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41419-026-08460-3","article-title":"CD36 enhances sensitivity of triple negative breast cancer cells to palmitate-induced ferroptosis","volume":"17","author":"Closset","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.110444_bb0070","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12943-025-02445-0","article-title":"Advances in novel cell death mechanisms in breast cancer: intersecting perspectives on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis","volume":"24","author":"Jing","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2026.110444_bb0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110444_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115866","article-title":"Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer","volume":"169","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.110444_bb0085","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.bioorg.2026.110444_bb0090","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41418-019-0393-7","article-title":"Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism","volume":"27","author":"Chen","year":"2019","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/j.bioorg.2026.110444_bb0095","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/jcb.27456","article-title":"Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5","volume":"120","author":"Lee","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2026.110444_bb0100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","article-title":"Connecting copper and cancer: from transition metal signalling to metalloplasia","volume":"22","author":"Ge","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110444_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111634","article-title":"Copper in tumors and the use of copper-based compounds in cancer treatment","volume":"226","author":"da Silva","year":"2022","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2026.110444_bb0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/ph16020234","article-title":"Potential of copper and copper compounds for anticancer applications","volume":"16","author":"Ji","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110444_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214307","article-title":"Latest developments in metal complexes as anticancer agents","volume":"452","author":"Paprocka","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110444_bb0120","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110444_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116211","article-title":"A review on metal complexes and its anti-cancer activities: recent updates from in vivo studies","volume":"171","author":"Adhikari","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.110444_bb0130","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.3390\/ijms24087289","article-title":"Metal-based complexes in cancer","volume":"24","author":"Riccardi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110444_bb0135","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1039\/C5MT00149H","article-title":"Targeting copper in cancer therapy: 'copper that cancer'","volume":"7","author":"Denoyer","year":"2015","journal-title":"Metallomics"},{"key":"10.1016\/j.bioorg.2026.110444_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ctrv.2008.07.004","article-title":"Elevated copper and oxidative stress in cancer cells as a target for cancer treatment","volume":"35","author":"Gupte","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bioorg.2026.110444_bb0145","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","article-title":"Copper-dependent autophagic degradation of GPX4 drives ferroptosis","volume":"19","author":"Xue","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.bioorg.2026.110444_bb0150","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","article-title":"Copper metabolism in cell death and autophagy","volume":"19","author":"Xue","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.bioorg.2026.110444_bb0155","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1021\/acs.jmedchem.4c02515","article-title":"Copper(II) complexes of pyrazolopyrimidine derivatives as anticancer agents with enhanced chemodynamic therapy through bimodal apoptosis and ferroptosis","volume":"68","author":"Yang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110444_bb0160","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110444_bb0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41571-026-01128-z","article-title":"Translating ferroptosis into oncology: challenges, opportunities and future directions","volume":"23","author":"Kang","year":"2026","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.110444_bb0170","doi-asserted-by":"crossref","first-page":"186","DOI":"10.31083\/j.fbl2808186","article-title":"Disulfiram\/copper induce ferroptosis in triple-negative breast cancer cell line MDA-MB-231","volume":"28","author":"Chu","year":"2023","journal-title":"Front. Biosci. Landmark"},{"key":"10.1016\/j.bioorg.2026.110444_bb0175","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/cancers12010138","article-title":"Disulfiram\/copper induces antitumor activity against both nasopharyngeal cancer cells and cancer-associated fibroblasts through ROS\/MAPK and ferroptosis pathways","volume":"12","author":"Li","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.110444_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202310342","article-title":"Progress and challenges in tumor ferroptosis treatment strategies: a comprehensive review of metal complexes and nanomedicine","volume":"20","author":"Su","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.bioorg.2026.110444_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2021.120384","article-title":"Zn and cu complexes of o-van-gly Schiff base: syntheses, crystal structures, fluorescence sensing and anticancer properties","volume":"522","author":"Liu","year":"2021","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.bioorg.2026.110444_bb0190","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-016-0330-x","article-title":"The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms","volume":"9","author":"Guo","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.110444_bb0195","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted pt(II) agents, nanoparticle delivery, and pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110444_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215231","article-title":"Recent developments on other platinum metal complexes as target-specific anticancer therapeutics","volume":"490","author":"Prathima","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110444_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: the first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110444_bb0210","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110444_bb0215","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.110444_bb0220","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110444_bb0225","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.bioorg.2026.110444_bb0230","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41419-019-2064-5","article-title":"ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation","volume":"10","author":"Park","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.110444_bb0235","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41419-022-05242-5","article-title":"Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.110444_bb0240","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3390\/biomedicines13082037","article-title":"Ferroptosis as a therapeutic avenue in triple-negative breast cancer: mechanistic insights and prognostic potential","volume":"13","author":"Riaz","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2026.110444_bb0245","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10549-024-07387-7","article-title":"Ferroptosis as a promising targeted therapy for triple negative breast cancer","volume":"207","author":"Mokhtarpour","year":"2024","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:26:09Z","timestamp":1791260769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"alternative-id":["S0045206826009806"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110444","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumor activity of a Schiff base copper(II) complex against triple-negative breast cancer via ferroptosis and autophagy pathways","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110444"}}